# Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg.

> **NCT01935570** · PHASE1 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 17 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Magnesium chloride (ChronoMag Smart Tablet®)
- **DRUG:** Magnesium carbonate (Mag2® Tablet)

## Key facts

- **NCT ID:** NCT01935570
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-07-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01935570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01935570, "Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01935570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*